Efficacy and Safety of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) for Type 2 Diabetes Mellitus (T2DM)

被引：0
|
作者：
Ford, Daniel M.
Baz-Hecht, Merav
Said, Nabil A.
Tao, Ben
Truitt, Kenneth E.
Chou, Hubert S.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1060-P
引用
收藏
页码：A273 / A273
页数：1
相关论文
共 50 条
  • [1] Effect of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) on Lipid Particles in Type 2 Diabetes Mellitus (T2DM)
    Jones, Michael R.
    Ford, Daniel M.
    Baz-Hecht, Merav
    Tao, Ben
    Truitt, Kenneth E.
    Chou, Hubert S.
    [J]. DIABETES, 2013, 62 : A302 - A302
  • [2] Colesevelam HCl reduces postprandial glucose in patients with type 2 diabetes mellitus (T2DM)
    Zieve, Franklin
    Schwartz, Sherwyn L.
    Kalin, Marcia
    Jones, Michael R.
    [J]. DIABETES, 2006, 55 : A140 - A140
  • [3] Efficacy and Safety of Canagliflozin (CANA) in Subjects With Type 2 Diabetes Mellitus (T2DM) on Metformin (MET) and Pioglitazone (PIO) Over 52 Weeks
    Forst, Thomas
    Guthrie, Robert
    Goldenberg, Ronald
    Yee, Jacqueline
    Vijapurkar, Ujjwala
    Meininger, Gary
    Stein, Peter
    [J]. DIABETES, 2013, 62 : A284 - A284
  • [4] Safety and tolerability of colesevelam HCl in patients with T2DM
    Schwartz, Sherwyn L.
    Zieve, Franklin
    Kalin, Marcia
    Jones, Michael R.
    [J]. DIABETES, 2006, 55 : A480 - A480
  • [5] Efficacy and Safety of Saxagliptin Add-on to Metformin Compared with Acarbose Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin Monotherapy
    Du, Jin
    Liang, Li
    Fang, Hui
    Xu, Fengmei
    Li, Wei
    Shen, Liya
    Mu, Yiming
    [J]. DIABETES, 2016, 65 : A293 - A293
  • [6] Saxagliptin vs Glipizide as Add-On Therapy to Metformin for Type 2 Diabetes Mellitus (T2DM): Long-Term Safety and Efficacy
    Goeke, Burkhard
    Gallwitz, Baptist
    Eriksson, Johan
    Bokelund-Singh, Sara
    Gause-Nilsson, Ingrid
    [J]. DIABETES, 2011, 60 : A305 - A305
  • [7] Efficacy and Safety of Colesevelam in Combination with Pioglitazone in Patients with Type 2 Diabetes Mellitus
    Rosenstock, J.
    Truitt, K. E.
    Baz-Hecht, M.
    Ford, D. M.
    Tao, B.
    Chou, H. S.
    [J]. HORMONE AND METABOLIC RESEARCH, 2014, 46 (13) : 943 - 949
  • [8] Pioglitazone (PIO) enhances insulin sensitivity (IS) in patients with type 2 diabetes (T2DM)
    Johns, D
    Herz, M
    Tan, MH
    Robertson, KE
    Gonzalez, B
    Reviriego, J
    Grossman, LD
    [J]. DIABETES, 2002, 51 : A102 - A102
  • [9] Vildagliptin as add-on to insulin in patients with type 2 diabetes (T2DM)
    Fonseca, Vivian
    Dejager, Sylvie
    Albrecht, Diego
    Shirt, Lynda
    Schweizer, Anja
    [J]. DIABETES, 2006, 55 : A111 - A111
  • [10] Empagliflozin (EMPA) for ≥76 Weeks As Add-on to Pioglitazone with or without Metformin in Patients with Type 2 Diabetes (T2DM)
    Kovacs, Christopher Simon
    Seshiah, Veeraswamy
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans-Juergen
    Broedl, Uli C.
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
12345